Extract to table
Pull the structured facts out of a document: parties, dates, amounts, obligations.
Extract to table / tax-implications-memo.docx
tax-implications-memo.docx
Parties
Solstice Biomedical Devices Ltd
Harkness LLP
Ireland Inc
Irish Corp
Byrne LLP
Keystone Valuation Advisors LLC
Federal Inc
Bennington LLP
Dates
June 9, 2025
June 30, 2025
September 15, 2025
January 10, 2038
May 9, 2024
November 14, 2017
June 22, 2035
April 30, 2019
September 15, 2036
March 3, 2020
Amounts
$8,750,000
$5,250,000
$3,500,000
$74,600,000
$31,800,000
$907,500
$24,200,000
$22,400,000
$500,000
$1,800,000
Obligations
Subsidiary must comply with the arm's-length principle under both IRC § 482 and Part 35A of the Taxes Consolidation Act 1997 (as amended by Finance Act 2019)
Although the lump-sum payment is deductible in principle under § 162(a), an important subsidiary question is whether any portion of the payment must be capitalized rather than currently expensed
Under IRC § 263(a), amounts paid to acquire, produce, or improve tangible or intangible property must be capitalized
79 (1992), held that a taxpayer must capitalize an expenditure that creates or enhances a separate and distinct asset or produces significant future benefits beyond the current taxable year
If any portion of the lump-sum is capitalized as a cost of acquiring the non-exclusive patent license, the applicable amortization provision must be determined
is a Delaware C-corporation and, based on its revenue level and corporate structure, is required to use the accrual method of accounting for federal income tax purposes